Can I switch from Wegovy to retatrutide
For researchers calculating per-vial research coverage against budget, our peptide calculator lets you quickly work out how reconstitution volume translates to research units per vial
Emerging evidence suggests that treatment with the dual GLP-1 and GIP receptor agonist, tirzepatide, might prove even more potent than a GLP-1RA alone, to ameliorate NAFLD
A person starting at 250 pounds loses different absolute amounts than someone starting at 180 pounds, but the percentage trajectory remains remarkably similar
As of 2025, retatrutide is not approved for use in the United Kingdom and is not available through the NHS or private prescription
For patients receiving tirzepatide treatment, these measures can minimize treatment disruption